ArriVent BioPharma Semi Variance
| AVBP Stock | | | 28.85 -0.77 -2.60% |
Semi-variance provides a good measure of downside volatility for equity or a portfolio. It is similar to variance, but it only looks at periods where the returns are less than the target or average level. Below is ArriVent BioPharma's current Semi Variance with peer comparisons and related risk metrics.
Current Semi Variance Value
ArriVent BioPharma registers a Semi Variance of 5.79, reflecting elevated price variability. This places ArriVent BioPharma toward the higher end of the volatility range for Stock.
Semi Variance | = | SUM(RET DEV)2N(ZERO) |
| = | 5.79 | |
| SUM | = | Summation notation |
| RET DEV | = | Actual return deviation over selected period |
| N(ZERO) | = | Number of points with returns less than zero |
Semi Variance Peers Comparison
The peer group averages 34.09 for Semi Variance, with ArriVent BioPharma at 5.79 falling below that level. Readings span 1.15 (Day One Biopharmaceuticals) to 86.89 (Erasca Inc). ArriVent BioPharma has exhibited less price dispersion than the peer average over the measured period.
Semi Variance Relative To Other Indicators
The chart below plots Semi Variance against Maximum Drawdown for ArriVent BioPharma and its peers. Each point represents one equity — position along the horizontal axis shows Semi Variance while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
ArriVent BioPharma's Semi Variance reads
5.79 while Maximum Drawdown reads
18.15 , a
3.14 ratio between the two. This indicates Maximum Drawdown is significantly higher than Semi Variance for ArriVent BioPharma.
Methodology, Assumptions & Data Sources
ArriVent BioPharma has a current Semi Variance reading of 5.79. The Semi Variance for ArriVent BioPharma applies a standardized calculation to daily closing prices and, where applicable, volume data across the selected period. Data sources include daily closing prices from supported exchanges, with standard corporate action adjustments applied. Results are based on historical returns and do not predict future performance. This indicator is provided for informational purposes.
Other Technical Indicators